IN2014CN03920A - - Google Patents

Download PDF

Info

Publication number
IN2014CN03920A
IN2014CN03920A IN3920CHN2014A IN2014CN03920A IN 2014CN03920 A IN2014CN03920 A IN 2014CN03920A IN 3920CHN2014 A IN3920CHN2014 A IN 3920CHN2014A IN 2014CN03920 A IN2014CN03920 A IN 2014CN03920A
Authority
IN
India
Prior art keywords
mice
mouse
encoding sequence
replacement
human
Prior art date
Application number
Other languages
English (en)
Inventor
Li Hsien Wang
Jr Anthony T Dore
Sean Stevens
Andrew J Murphy
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Publication of IN2014CN03920A publication Critical patent/IN2014CN03920A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Environmental Sciences (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN3920CHN2014 2011-10-28 2012-10-29 IN2014CN03920A (cs)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161552900P 2011-10-28 2011-10-28
US201161556579P 2011-11-07 2011-11-07
PCT/US2012/062379 WO2013063556A1 (en) 2011-10-28 2012-10-29 Humanized il-6 and il-6 receptor

Publications (1)

Publication Number Publication Date
IN2014CN03920A true IN2014CN03920A (cs) 2015-09-04

Family

ID=47295138

Family Applications (1)

Application Number Title Priority Date Filing Date
IN3920CHN2014 IN2014CN03920A (cs) 2011-10-28 2012-10-29

Country Status (27)

Country Link
US (10) US8878001B2 (cs)
EP (2) EP2663575B1 (cs)
JP (2) JP6120451B2 (cs)
KR (2) KR102084927B1 (cs)
CN (2) CN104039821A (cs)
AU (1) AU2015207889B2 (cs)
BR (1) BR112014008529A2 (cs)
CA (1) CA2853731C (cs)
CY (2) CY1116614T1 (cs)
DK (2) DK2818478T3 (cs)
ES (2) ES2624605T3 (cs)
HR (2) HRP20141192T1 (cs)
HU (1) HUE033400T2 (cs)
IL (4) IL231896B (cs)
IN (1) IN2014CN03920A (cs)
LT (1) LT2818478T (cs)
MX (1) MX358390B (cs)
MY (2) MY172726A (cs)
PL (2) PL2663575T3 (cs)
PT (2) PT2818478T (cs)
RS (2) RS53683B1 (cs)
RU (2) RU2634417C2 (cs)
SG (3) SG10201600965YA (cs)
SI (2) SI2663575T1 (cs)
SM (2) SMT201700222T1 (cs)
WO (1) WO2013063556A1 (cs)
ZA (1) ZA201402635B (cs)

Families Citing this family (78)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3417701B1 (en) 2009-10-06 2021-12-15 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
ES3040596T3 (en) 2011-02-15 2025-11-03 Regeneron Pharma Humanized m-csf mice and uses thereof
LT2818478T (lt) 2011-10-28 2017-06-12 Regeneron Pharmaceuticals, Inc. Humanizuotas il-6 ir il-6 receptorius
US20130261016A1 (en) * 2012-03-28 2013-10-03 Meso Scale Technologies, Llc Diagnostic methods for inflammatory disorders
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
KR102287541B1 (ko) 2012-09-07 2021-08-10 예일 유니버시티 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법
CN104797132B (zh) * 2012-09-13 2017-06-30 中外制药株式会社 基因敲入非人动物
KR102768101B1 (ko) 2012-11-05 2025-02-18 리제너론 파마슈티칼스 인코포레이티드 유전자 변형된 비-인간 동물 및 그것의 사용 방법
SMT201900429T1 (it) 2013-02-20 2019-09-09 Regeneron Pharma Topi esprimenti co-recettori umanizzati linfociti t
ES2949029T3 (es) 2013-02-22 2023-09-25 Regeneron Pharma Células murinas que expresan complejo mayor de histocompatibilidad humanizado
GB2513884B (en) 2013-05-08 2015-06-17 Univ Bristol Method and apparatus for producing an acoustic field
PL4269430T3 (pl) 2013-09-23 2025-10-13 Regeneron Pharmaceuticals, Inc. Zwierzęta inne niż człowiek posiadające humanizowany gen białka regulującego sygnalizację
EP3138397B1 (en) * 2013-10-15 2018-12-26 Regeneron Pharmaceuticals, Inc. Humanized il-15 animals
EP3071024B1 (en) * 2013-11-19 2018-09-05 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized b-cell activating factor gene
WO2015077072A1 (en) 2013-11-19 2015-05-28 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized a proliferation-inducing ligand gene
US9612658B2 (en) 2014-01-07 2017-04-04 Ultrahaptics Ip Ltd Method and apparatus for providing tactile sensations
MX367661B (es) 2014-01-31 2019-08-30 Boehringer Ingelheim Int Anticuerpos anti-baff novedosos.
LT3129400T (lt) 2014-04-08 2020-06-25 Regeneron Pharmaceuticals, Inc. Gyvūnai, išskyrus žmogų, turintys humanizuotus fc-gama receptorius
WO2015171523A1 (en) 2014-05-05 2015-11-12 Regeneron Pharmaceuticals, Inc. Humanized c5 and c3 animals
NO2785538T3 (cs) * 2014-05-07 2018-08-04
RU2711744C1 (ru) 2014-05-19 2020-01-21 Ридженерон Фармасьютикалз, Инк. Генетически модифицированные животные, отличные от человека, экспрессирующие epo человека
NZ726355A (en) 2014-05-30 2018-08-31 Regeneron Pharma Humanized dipeptidyl peptidase iv (dpp4) animals
ES2783424T3 (es) 2014-06-19 2020-09-17 Regeneron Pharma Animales no humanos que tienen un gen de muerte celular programada 1 humanizado
GB2530036A (en) 2014-09-09 2016-03-16 Ultrahaptics Ltd Method and apparatus for modulating haptic feedback
LT3689140T (lt) 2014-11-24 2022-08-25 Regeneron Pharmaceuticals, Inc. Gyvūnai, išskyrus žmones, ekspresuojantys humanizuotą cd3 kompleksą
PT3466255T (pt) * 2014-12-05 2021-05-10 Regeneron Pharma Animais não humanos tendo um gene do cluster humanizado de diferenciação 47
SI3808775T1 (sl) 2014-12-09 2024-08-30 Regeneron Pharmaceuticals, Inc. Nehumane živali s humaniziranim genom označevalca pripadnosti 274
SG11201706557SA (en) 2015-02-20 2017-09-28 Ultrahaptics Ip Ltd Perceptions in a haptic system
US10101811B2 (en) 2015-02-20 2018-10-16 Ultrahaptics Ip Ltd. Algorithm improvements in a haptic system
CN107666828B (zh) 2015-04-06 2021-04-09 瑞泽恩制药公司 非人动物中的人源化t细胞介导的免疫应答
IL302370B2 (en) 2015-04-13 2025-10-01 Regeneron Pharma Mice genetically engineered to express alpha signal modulator protein and interleukin 15 and methods for using them
US10818162B2 (en) 2015-07-16 2020-10-27 Ultrahaptics Ip Ltd Calibration techniques in haptic systems
MX2018005389A (es) 2015-11-20 2018-09-05 Regeneron Pharma Animales no humanos que tienen un gen 3 de activacion linfocitaria humanizado.
NZ783252A (en) 2015-12-08 2024-12-20 Regeneron Pharma Compositions and methods for internalizing enzymes
US11189140B2 (en) 2016-01-05 2021-11-30 Ultrahaptics Ip Ltd Calibration and detection techniques in haptic systems
CN108779159B (zh) 2016-02-04 2022-12-30 瑞泽恩制药公司 具有经改造的angptl8基因的非人动物
CN109068621B (zh) 2016-02-29 2021-07-20 再生元制药公司 具有人源化的tmprss基因的啮齿类动物
EP3462853B1 (en) 2016-06-03 2023-03-01 Regeneron Pharmaceuticals, Inc. Rodents expressing exogenous terminal deoxynucleotidyltransferase
US10531212B2 (en) 2016-06-17 2020-01-07 Ultrahaptics Ip Ltd. Acoustic transducers in haptic systems
US10268275B2 (en) 2016-08-03 2019-04-23 Ultrahaptics Ip Ltd Three-dimensional perceptions in haptic systems
US10755538B2 (en) 2016-08-09 2020-08-25 Ultrahaptics ilP LTD Metamaterials and acoustic lenses in haptic systems
CN107815467B (zh) * 2016-08-31 2021-03-16 百奥赛图(北京)医药科技股份有限公司 人源化基因改造动物模型的制备方法及应用
US10943578B2 (en) 2016-12-13 2021-03-09 Ultrahaptics Ip Ltd Driving techniques for phased-array systems
US10497358B2 (en) 2016-12-23 2019-12-03 Ultrahaptics Ip Ltd Transducer driver
CN108467873B (zh) 2017-03-17 2020-03-13 百奥赛图江苏基因生物技术有限公司 一种cd132基因缺失的免疫缺陷动物模型的制备方法及应用
WO2018177441A1 (en) 2017-03-31 2018-10-04 Beijing Biocytogen Co., Ltd GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPα
CN108588126B (zh) 2017-03-31 2020-04-10 北京百奥赛图基因生物技术有限公司 Cd47基因人源化改造动物模型的制备方法及应用
CN111163633B (zh) 2017-09-29 2022-09-09 瑞泽恩制药公司 包含人源化ttr基因座的非人类动物及其使用方法
US11531395B2 (en) 2017-11-26 2022-12-20 Ultrahaptics Ip Ltd Haptic effects from focused acoustic fields
SG11202002456WA (en) 2017-11-30 2020-04-29 Regeneron Pharma Non-human animals comprising a humanized trkb locus
EP3729417B1 (en) 2017-12-22 2025-09-10 Ultrahaptics Ip Ltd Tracking in haptic systems
WO2019122916A1 (en) 2017-12-22 2019-06-27 Ultrahaptics Limited Minimizing unwanted responses in haptic systems
KR102840787B1 (ko) 2018-03-26 2025-07-31 리제너론 파마슈티칼스 인코포레이티드 치료제를 시험하기 위한 인간화된 설치류
EP4414556A3 (en) 2018-05-02 2024-10-23 Ultrahaptics IP Limited Blocking plate structure for improved acoustic transmission efficiency
PT3823443T (pt) * 2018-07-16 2024-07-29 Regeneron Pharma Modelos de roedores da-doença ditra e as suas utilizações
US11098951B2 (en) 2018-09-09 2021-08-24 Ultrahaptics Ip Ltd Ultrasonic-assisted liquid manipulation
US11378997B2 (en) 2018-10-12 2022-07-05 Ultrahaptics Ip Ltd Variable phase and frequency pulse-width modulation technique
WO2020125639A1 (en) * 2018-12-17 2020-06-25 Biocytogen Jiangsu Co., Ltd. Genetically modified non-human animal with human or chimeric genes
US12373033B2 (en) 2019-01-04 2025-07-29 Ultrahaptics Ip Ltd Mid-air haptic textures
EP3906462B1 (en) 2019-01-04 2025-06-18 Ultrahaptics IP Ltd Mid-air haptic textures
CN114164177A (zh) * 2019-01-17 2022-03-11 百奥赛图(北京)医药科技股份有限公司 人源化转基因动物
ES2966625T3 (es) 2019-04-04 2024-04-23 Regeneron Pharma Roedores que comprenden un locus del factor de coagulación 12 humanizado
US11842517B2 (en) 2019-04-12 2023-12-12 Ultrahaptics Ip Ltd Using iterative 3D-model fitting for domain adaptation of a hand-pose-estimation neural network
CN113853433A (zh) * 2019-05-27 2021-12-28 转基因股份有限公司 外显子人源化小鼠
EP3801011A1 (en) 2019-06-04 2021-04-14 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized ttr locus with a beta-slip mutation and methods of use
WO2020247812A1 (en) 2019-06-07 2020-12-10 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized albumin locus
KR20220080737A (ko) 2019-10-13 2022-06-14 울트라립 리미티드 가상 마이크로폰들에 의한 동적 캡핑
US11374586B2 (en) 2019-10-13 2022-06-28 Ultraleap Limited Reducing harmonic distortion by dithering
WO2021090028A1 (en) 2019-11-08 2021-05-14 Ultraleap Limited Tracking techniques in haptics systems
CN111304246B (zh) * 2019-12-17 2021-05-04 百奥赛图江苏基因生物技术有限公司 一种人源化细胞因子动物模型、制备方法及应用
US11715453B2 (en) 2019-12-25 2023-08-01 Ultraleap Limited Acoustic transducer structures
KR20220133248A (ko) * 2020-01-28 2022-10-04 리제너론 파마슈티칼스 인코포레이티드 인간화 pnpla3 좌위를 포함하는 비-인간 동물 및 사용 방법
JP7765403B2 (ja) 2020-04-21 2025-11-06 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒト化ｃｘｃｌ１３遺伝子を有する非ヒト動物
US11816267B2 (en) 2020-06-23 2023-11-14 Ultraleap Limited Features of airborne ultrasonic fields
US11886639B2 (en) 2020-09-17 2024-01-30 Ultraleap Limited Ultrahapticons
CN116981357A (zh) 2021-03-31 2023-10-31 瑞泽恩制药公司 包含具有改善的tcrb组库多样性的人源化细胞免疫系统组分的基因修饰的小鼠
WO2024073679A1 (en) 2022-09-29 2024-04-04 Regeneron Pharmaceuticals, Inc. Correction of hepatosteatosis in humanized liver animals through restoration of il6/il6r/gp130 signaling in human hepatocytes
WO2025212991A1 (en) 2024-04-05 2025-10-09 Regeneron Pharmaceuticals, Inc. Rodent models of disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10509586A (ja) * 1994-10-14 1998-09-22 ベーアーエスエフ アクツィエンゲゼルシャフト 機能的に破壊されたインターロイキン−１β変換酵素遺伝子を有するトランスジェニック非ヒト動物
EP2319535A3 (en) 1994-10-21 2011-08-31 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for treatment of diseases caused by IL-6 production
US20030082721A1 (en) * 2001-01-17 2003-05-01 Tai-Jay Chang Transgenic animals expressing androgen receptor complex-associated protein
CN1560081A (zh) * 2004-02-17 2005-01-05 大连帝恩生物工程有限公司 用能产生人IgGl重链－κ轻链小鼠作为制备人源化单克隆抗体和应用
PT2767161T (pt) * 2004-10-19 2018-04-20 Regeneron Pharma Método para gerar um animal homozigótico para uma modificação genética
US7759541B2 (en) 2004-12-13 2010-07-20 Iti Life Sciences Transgenic animals for assessing drug metabolism and toxicity
GB2434578A (en) 2006-01-26 2007-08-01 Univ Basel Transgenic animals
ATE537190T1 (de) 2006-06-02 2011-12-15 Regeneron Pharma Hochaffine antikörper gegen den humanen il-6- rezeptor
JP5087625B2 (ja) * 2006-09-01 2012-12-05 セラピューティック・ヒューマン・ポリクローナルズ・インコーポレーテッド 非ヒトトランスジェニック動物におけるヒトまたはヒト化免疫グロブリンの発現強化
FR2942218A1 (fr) 2009-02-13 2010-08-20 Eurocave Sa Appareil de service au verre d'un liquide, notamment de vin
EP3417701B1 (en) * 2009-10-06 2021-12-15 Regeneron Pharmaceuticals, Inc. Genetically modified mice and engraftment
SI2516457T1 (en) * 2009-12-21 2018-08-31 Regeneron Pharmaceuticals, Inc. MUSHROOM WITH HUMANIZED FC GAMES R
ES3040596T3 (en) 2011-02-15 2025-11-03 Regeneron Pharma Humanized m-csf mice and uses thereof
JP6352634B2 (ja) 2011-09-30 2018-07-04 中外製薬株式会社 標的抗原に対する免疫応答を誘導する抗原結合分子
LT2818478T (lt) 2011-10-28 2017-06-12 Regeneron Pharmaceuticals, Inc. Humanizuotas il-6 ir il-6 receptorius
ES2651517T3 (es) 2011-10-28 2018-01-26 Regeneron Pharmaceuticals, Inc. Ratones con complejo mayor de histocompatibilidad modificado genéticamente
MX379060B (es) 2011-10-28 2025-03-10 Regeneron Pharma Ratones transgenicos que expresan moleculas quimericas del complejo mayor de histocompatibilidad (cmh) clase ii.

Also Published As

Publication number Publication date
WO2013063556A4 (en) 2013-06-20
CY1118952T1 (el) 2018-01-10
RU2017129763A3 (cs) 2020-12-18
US11102962B2 (en) 2021-08-31
JP2017035115A (ja) 2017-02-16
US20220053742A1 (en) 2022-02-24
IL231896A0 (en) 2014-05-28
RS53683B1 (sr) 2015-04-30
US20150272092A1 (en) 2015-10-01
US20200008407A1 (en) 2020-01-09
DK2663575T3 (en) 2014-12-15
EP2818478B1 (en) 2017-02-01
WO2013063556A8 (en) 2014-04-17
ZA201402635B (en) 2015-09-30
RU2751240C2 (ru) 2021-07-12
US20150013023A1 (en) 2015-01-08
CA2853731C (en) 2021-05-18
US20150013022A1 (en) 2015-01-08
ES2525368T3 (es) 2014-12-23
IL264508B (en) 2019-12-31
US9125386B2 (en) 2015-09-08
IL243665A0 (en) 2016-03-31
US8878001B2 (en) 2014-11-04
CA2853731A1 (en) 2013-05-02
KR102084927B1 (ko) 2020-03-06
NZ623145A (en) 2015-09-25
HK1205135A1 (en) 2015-12-11
IL243666A0 (en) 2016-03-31
EP2663575A1 (en) 2013-11-20
US9622460B2 (en) 2017-04-18
JP2014532416A (ja) 2014-12-08
KR102234632B1 (ko) 2021-04-02
DK2818478T3 (en) 2017-05-22
CN108866101A (zh) 2018-11-23
WO2013063556A1 (en) 2013-05-02
MX2014004900A (es) 2014-08-26
SG11201400945UA (en) 2014-04-28
SMT201400187B (it) 2015-01-15
US20180271071A1 (en) 2018-09-27
AU2015207889A1 (en) 2015-08-20
RU2017129763A (ru) 2019-02-05
IL243666B (en) 2019-02-28
MY172726A (en) 2019-12-11
RU2634417C2 (ru) 2017-10-26
US9392777B2 (en) 2016-07-19
SI2663575T1 (sl) 2015-01-30
SMT201700222T1 (it) 2017-07-18
IL264508A (en) 2019-02-28
US10433528B2 (en) 2019-10-08
KR20200024949A (ko) 2020-03-09
CN104039821A (zh) 2014-09-10
US20130117873A1 (en) 2013-05-09
PL2663575T3 (pl) 2015-03-31
RU2014121324A (ru) 2015-12-10
PT2663575E (pt) 2014-12-05
US10004211B2 (en) 2018-06-26
US20250287931A1 (en) 2025-09-18
HK1190408A1 (en) 2014-07-04
KR20140091024A (ko) 2014-07-18
US12239111B2 (en) 2025-03-04
SI2818478T1 (sl) 2017-07-31
AU2015207889B2 (en) 2017-02-23
MX358390B (es) 2018-08-17
HUE033400T2 (en) 2017-12-28
HRP20170656T1 (hr) 2017-06-30
JP6120451B2 (ja) 2017-04-26
MY186903A (en) 2021-08-26
IL231896B (en) 2018-02-28
ES2624605T3 (es) 2017-07-17
US20160278352A1 (en) 2016-09-29
US9078418B2 (en) 2015-07-14
NZ709432A (en) 2015-12-24
BR112014008529A2 (pt) 2017-04-18
CY1116614T1 (el) 2017-03-15
PL2818478T3 (pl) 2017-09-29
PT2818478T (pt) 2017-05-12
IL243665B (en) 2018-02-28
EP2818478A1 (en) 2014-12-31
SG10202100485XA (en) 2021-02-25
LT2818478T (lt) 2017-06-12
RS55949B1 (sr) 2017-09-29
HRP20141192T1 (hr) 2015-02-13
US20170055506A1 (en) 2017-03-02
EP2663575B1 (en) 2014-10-01
SG10201600965YA (en) 2016-03-30

Similar Documents

Publication Publication Date Title
IN2014CN03920A (cs)
SG10201902547SA (en) Non-human animals having a humanized signal-regulatory protein gene
NZ702943A (en) Humanized il-7 rodents
GB2552617B (en) A user interface and system for supplying gases to an airway
SG10201900323SA (en) Method for inducing t cells for cell-based immunotherapy from pluripotent stem cells
LT3248462T (lt) Pelių genų inžinerija, skirta chimerinių antikūnų gamybai
HK1222205A1 (zh) 由多能干细胞产生的光感受器和光感受器袓细胞
MX2013015311A (es) Polipeptidos de enlace de pcsk9 y metodos de uso.
TW201129697A (en) Herbicide-tolerant plants
PH12014500348A1 (en) Genes and proteins for alkanoyl-coa synthesis
MY173936A (en) Humanized light chain mice field of invention
PH12016502170A1 (en) Humanized dipeptidyl peptidase iv (dpp4) animals
EP2635879A4 (en) Systems and methods for generating updates of geological models
PH12015502421A1 (en) Artificial transcription factors engineered to overcome endosomal entrapment
GB2498325A (en) Modulation neural pathways
MX2012007898A (es) Metodos para proveer terapia de perdida de peso en pacientes con depresion mayor.
NZ609594A (en) Eph receptor expression in tumor stem cells
WO2014152607A3 (en) Dosage compensating transgenes and cells
MX356317B (es) Tratamiento de síntomas asociados a gastroparesia femenina.
MX2016003248A (es) Metodos de uso de anticuerpos anti-lgr5.
EP2787080A4 (en) PROMOTER FROM THE HUMAN GEN
MX377591B (es) Elementos promotores y reguladores para mejorar la expresión de genes heterólogos en células hospederas.
TH148340A (th) อินเตอร์ลิวคิน 6 (il-6) ที่มีลักษณะมนุษย์และตัวรับอินเตอร์ลิวคิน6 (il-6)
IN2014CH05016A (cs)
Molgora et al. Interleukin-1 receptor 8 (IL-1R8) plays a crucial role in NK cell differentiation and function